Drugs / Iodofiltic acid I 123
last change Jul 2010 re-read 3 minutes ago

Iodofiltic acid I 123

Diagnostic / imaging agent

Investigated by
Molecular Insight Pharmaceuticals, Inc.

Trials 1

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00514501 May 2007 → Jun 2008 acute coronary syndrome Molecular Insight Pharmaceuticals, Inc. Completed No outcome recorded

Evidence & citations 9 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as Iodofiltic acid I 123 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00514501 ↗
Known as 123i-bmipp ChEMBL registry synonym — accepted as the source's own label CHEMBL336360 ↗
Known as Acide iodofiltique (123i) ChEMBL registry synonym — accepted as the source's own label CHEMBL336360 ↗
Known as Acido iodofiltico (123i) ChEMBL registry synonym — accepted as the source's own label CHEMBL336360 ↗
Known as BMIP-P I-123 ChEMBL registry synonym — accepted as the source's own label CHEMBL336360 ↗
Known as BMIPP “Iodofiltic acid I 123 (BMIPP) fatty acid imaging improves initial diagnosis in emergency department patients with suspected acute coronary syndromes: a multicenter trial.” PMID 20633821 ↗ Jul 2010
Known as Iodofiltic acid (123i) ChEMBL registry synonym — accepted as the source's own label CHEMBL336360 ↗
Known as Zemiva ChEMBL registry synonym — accepted as the source's own label CHEMBL336360 ↗
Modality Diagnostic / imaging agent “Patients will be imaged with iodofiltic acid I 123 for the detection of myocardial ischemia.” NCT00514501 ↗